Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 3325-3329, July 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moyer, J. D.
Right arrow Articles by Marquez, V. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moyer, J. D.
Right arrow Articles by Marquez, V. E.

Antitumor Activity and Biochemical Effects of Cyclopentenyl Cytosine in Mice

James D. Moyer1, Nancy M. Malinowski, Susan P. Treanor and Victor E. Marquez

Laboratory of Biological Chemistry [J. D. M., N. M. M.] and Laboratory of Pharmacology and Experimental Therapeutics [S. P. T., V. E. M.], Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892

Cyclopentenyl cytosine, a recently synthesized inhibitor of cytidine 5'-triphosphate synthesis, has marked antitumor activity. Treatment with 1 mg/kg i.p. on days 1–9 following inoculation with tumor produced 111–122% increased median life span in mice bearing L1210 leukemia, 73–129% increased median life span in mice bearing P388 leukemia, and 58–62% increased median life span in mice with B16 melanoma. A subline of L1210 selected for resistance to 1-ß-D-arabinofuranosylcytosine was more sensitive to cyclopentenyl cytosine than the parent tumor line. L1210 cell growth in cultures was greatly inhibited (>90%) by 0.1 µM cyclopentenyl cytosine, but cells were protected from the growth inhibitory effects by cytidine (20 µM) and to a lesser extent by uridine or deoxycytidine. Exposure of cultured L1210 cells to 1 µM cyclopentenyl cytosine inhibited formation of [3H]cytidine nucleotides from [3H]uridine by 30% during the first 15 min of exposure to drug and by >95% after 2 h of exposure. Treatment of mice bearing L1210 ascites with cyclopentenyl cytosine (1 mg/kg) produced rapid depletion of cytidine nucleotide pools in the tumor cells; these pools fell to 35% of control within 30 min. The effects of cyclopentenyl cytosine on nucleotide pools were tissue selective; the cytidine nucleotide pools of spleen, liver, kidney, and intestine were less sensitive than that of the L1210 ascites tumor. Cytidine nucleotide pools of spleen and liver were depleted by higher doses (10 mg/kg) of cyclopentenyl cytosine.

1 To whom requests for reprints should be addressed.

Received 10/ 8/85. Revised 2/18/86. Accepted 3/24/86.




This article has been cited by other articles:


Home page
Genes Dev.Home page
S P Linke, K C Clarkin, A Di Leonardo, A Tsou, and G M Wahl
A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.
Genes & Dev., April 15, 1996; 10(8): 934 - 947.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.